T2 Biosystems (NASDAQ:TTOO) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report issued on Sunday morning. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

NASDAQ:TTOO opened at $0.13 on Friday. The company has a fifty day simple moving average of $0.24 and a two-hundred day simple moving average of $1.06. T2 Biosystems has a 52 week low of $0.06 and a 52 week high of $6.80.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.